Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 80.54B | 78.95B | 92.88B | 142.42B | 96.55B | 64.23B |
Gross Profit | 6.25B | 32.47B | 31.69B | 28.71B | 30.96B | 23.27B |
EBITDA | 25.37B | 22.74B | 18.30B | 18.18B | 13.70B | 14.08B |
Net Income | 6.30B | 7.02B | 3.44B | 5.22B | 3.19B | 3.62B |
Balance Sheet | ||||||
Total Assets | 179.44B | 187.14B | 195.22B | 219.62B | 206.94B | 163.45B |
Cash, Cash Equivalents and Short-Term Investments | 7.90B | 10.92B | 11.33B | 24.79B | 11.02B | 6.37B |
Total Debt | 65.63B | 70.35B | 73.56B | 87.91B | 70.92B | 58.66B |
Total Liabilities | 130.03B | 137.97B | 150.12B | 177.54B | 164.60B | 121.10B |
Stockholders Equity | 34.46B | 33.73B | 25.20B | 28.66B | 29.65B | 28.32B |
Cash Flow | ||||||
Free Cash Flow | 4.93B | 4.29B | 1.85B | -4.57B | -2.13B | 1.96B |
Operating Cash Flow | 12.92B | 13.22B | 14.62B | 8.67B | 10.07B | 11.51B |
Investing Cash Flow | -8.66B | -4.11B | -10.61B | -13.63B | -10.88B | -10.12B |
Financing Cash Flow | -10.35B | -7.99B | -8.36B | 7.37B | 3.78B | -3.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $6.54B | 4.95 | 22.94% | 15.50% | -3.27% | -3.44% | |
72 Outperform | $6.48B | 12.47 | 9.81% | 6.23% | -5.28% | 14.50% | |
71 Outperform | $93.45B | 13.55 | 19.75% | 5.69% | -7.90% | 24.57% | |
71 Outperform | $53.58B | 19.91 | 8.87% | 3.12% | 0.46% | -11.77% | |
66 Neutral | $17.25B | 17.99 | 5.54% | 3.64% | 6.63% | 11.55% | |
65 Neutral | $9.12B | 9.04 | 21.17% | 5.42% | -3.19% | 30.48% | |
63 Neutral | $19.87B | 1,570.10 | 1.06% | 5.56% | 8.86% | ― |